Phibro Animal Health Affirms FY2027 Adj EPS Guidance of $3.41-$3.59 vs $3.50 Est; Affirms FY2027 Sales Guidance of $1.550B-$1.600B vs $1.578B Est
Benzinga Newsdesk 3 hours ago
NewsGuidance
Phibro Animal Health (NASDAQ:PAHC) affirms FY2027 Adj EPS guidance from $3.41-$3.59 to $3.41-$3.59 vs $3.50 analyst estimate. Affirms FY2027 sales outlook from $1.550 billion-$1.600 billion to $1.550 billion-$1.600
Phibro Animal Health (NASDAQ:PAHC) affirms FY2027 Adj EPS guidance from $3.41-$3.59 to $3.41-$3.59 vs $3.50 analyst estimate. Affirms FY2027 sales outlook from $1.550 billion-$1.600 billion to $1.550 billion-$1.600 billion vs $1.578 billion estimate.